Prelude Capital Management’s Cellcom Israel, Ltd. CEL Stock Holding History

Prelude Capital Management’s Portfolio CEL Stock Details CEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,020	Closed	-$29K	–	1999
2017 Q2	$29K	Buy	+3,020	New	+$29.8K	﹤0.01%	1176
2016 Q3	–	Sell	-2,282	Closed	-$15K	–	1913
2016 Q2	$15K	Buy	+2,282	New	+$16.9K	﹤0.01%	1340
2016 Q1	–	Sell	-10,000	Closed	-$62K	–	1623
2015 Q4	$62K	Sell	10,000 -1,400	-12%	-$9.77K	0.01%	992
2015 Q3	$71K	Buy	+11,400	New	+$67.7K	0.01%	946

Other funds holding CEL

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Prelude Capital Management's CEL Position: Q3 2017 in Review

Prelude Capital Management sold out of Cellcom Israel, Ltd. (CEL) in Q3 2017, closing a stake of 3,020 shares — an estimated $29K sold.

Prelude Capital Management first reported a position in CEL in Q3 2015 and held it in 4 quarters. The position peaked at $71K in Q3 2015. 34 funds tracked by Wall St. Rank hold CEL as of Q3 2017.

Prelude Capital Management reported no remaining Cellcom Israel, Ltd. position as of Q3 2017 after selling out during the quarter.
Prelude Capital Management sold 3,020 Cellcom Israel, Ltd. shares in Q3 2017, an estimated $29K.
Prelude Capital Management first reported a position in Cellcom Israel, Ltd. in Q3 2015 and held it in 4 quarters.
Prelude Capital Management's Cellcom Israel, Ltd. position peaked at $71K in Q3 2015.
34 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q3 2017.

Based on Prelude Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.